Here are some of the major news updates:
1. Lupin gets FDA nod for Generic Ganirelix acetate, shares up
https://www.thehindubusinessline.com/markets/lupin-gets-fda-nod-for-generic-ganirelix-acetate-shares-up/article67543728.ece
2. Adani Energy announces ESG ratings
https://www.thehindubusinessline.com/markets/adani-energy-announces-esg-ratings/article67543649.ece
3. Aurobindo Pharma’s China plant gets EU’s GMP approval
https://www.thehindubusinessline.com/companies/aurobindo-pharmas-china-plant-gets-eus-gmp-approval/article67543581.ece
4. Religare can’t be personal fiefdom of a few, says Mohit Burman
https://www.thehindubusinessline.com/markets/takeover-tussle-religare-cant-be-personal-fiefdom-of-a-few-says-mohit-burman/article67543143.ece
5. #Listen: Decoding the goldilocks paradox: how RBI is managing inflation while supporting growth
https://www.thehindubusinessline.com/multimedia/decoding-the-goldilocks-paradox-how-rbi-is-managing-inflation-while-boosting-growth/article67540383.ece
1. Lupin gets FDA nod for Generic Ganirelix acetate, shares up
https://www.thehindubusinessline.com/markets/lupin-gets-fda-nod-for-generic-ganirelix-acetate-shares-up/article67543728.ece
2. Adani Energy announces ESG ratings
https://www.thehindubusinessline.com/markets/adani-energy-announces-esg-ratings/article67543649.ece
3. Aurobindo Pharma’s China plant gets EU’s GMP approval
https://www.thehindubusinessline.com/companies/aurobindo-pharmas-china-plant-gets-eus-gmp-approval/article67543581.ece
4. Religare can’t be personal fiefdom of a few, says Mohit Burman
https://www.thehindubusinessline.com/markets/takeover-tussle-religare-cant-be-personal-fiefdom-of-a-few-says-mohit-burman/article67543143.ece
5. #Listen: Decoding the goldilocks paradox: how RBI is managing inflation while supporting growth
https://www.thehindubusinessline.com/multimedia/decoding-the-goldilocks-paradox-how-rbi-is-managing-inflation-while-boosting-growth/article67540383.ece